Work
/
High-stakes projects
Pfizer's Melbourne facility was shortlisted for a major global investment — but recent project governance failures threatened the business case. Morgan built the governance framework, scaled a 20+ person team, and secured $80M in global capital funding.
Industry
Manufacturing
Pharmaceuticals
Challenge
Project governance failures risking global funding approval
Our Service
Project Governance & Delivery
Achievements
$80M approved by global stakeholders
CONTEXT
Pfizer was exploring opportunities to expand manufacturing capability and commercialise new products. The Melbourne facility had strong operational alignment and was shortlisted as a potential site. This presented an opportunity to secure significant investment and expand capacity.
PROBLEM
Recent CAPEX projects at the site had failed. Global stakeholders would not approve the $80M investment without confidence that the site had addressed the governance issues and was capable of delivering. There was a narrow window to achieve new product pipeline milestones. The product was forecast to be a blockbuster. The project received a lot of global stakeholder scrutiny.
WHAT WE DID
We diagnosed the governance gaps and built the frameworks, processes and accountability structures needed to restore confidence. We then made the case to global stakeholders, translating complex site-level challenges into a compelling $80M investment narrative that enabled confident decision-making. We built the capability to deliver by scaling the team and establishing clear roles, governance and readiness. Throughout construction and commissioning, we remained embedded, supporting delivery and keeping stakeholders aligned.
THE OUTCOME
The site secured a new product and manufacturing capability, strengthening its role in Pfizer's global network.
PROOF
CapEx investments approved
Consistent project governance processes adopted across the site
Let's chat.
We love solving complex problems.
Let's discuss yours.
Morgan
Simplify • Transform • Deliver
